
Can electric cars help strengthen electrical grids?
Chemical engineering doctoral candidate Heta Gandhi and her advisor, assistant professor Andrew White, have developed a new computer model showing ways to sell surplus energy from electric vehicles to local grids.

Researchers develop novel 3D printing technique to engineer biofilms
University of Rochester biologist Anne S. Meyer and her colleagues are studying how engineered biofilms closely mimic natural ones. Their research may aid in developing drugs to fight the negative effects of these microorganisms that adhere to surfaces.

Better models of atmospheric ‘detergent’ can help predict climate change
New research from Rochester scientist Lee Murray will aid in building more accurate computer models of the hydroxyl radical, an important ‘detergent of the atmosphere.’

Rochester researchers set ‘ultrabroadband’ record with entangled photons
Engineers have taken advantage of the quantum entanglement phenomenon to generate unprecedented bandwidth and brightness on chip-sized nanophotonic devices.

A big leap forward in using iron catalysts for pharmaceuticals
Researchers at Rochester and Maryland describe a novel cross-coupling reaction that could lead to a cheaper way to develop chemical compounds for pharmaceuticals.

New imaging system captures text from barely open books
Rochester textual scientist Gregory Heyworth led the development of a digitization method for books with fragile binding.

Is ‘junk DNA’ a key to killing cancer cells?
Rochester biologists show how a selfish genetic element called retrotransposons that can cause tumors may also trigger the death of cancer cells.

‘High risk’ project uses quantum science to unlock new chemical reactions
Rochester scientists have secured national funding for a multi-institutional research effort that could alter the basic rules of chemistry.

Meet one of Popular Science magazine’s ‘Brilliant 10’
Rochester biomedical engineer Michael Giacomelli is pursuing a quicker way to detect skin cancer.

Approach predicts novel ‘protein partners’ that could contribute to COVID-19 symptoms
Rochester biologists propose that disrupted interactions between the proteins that closely evolve with the ACE2 receptor may play a role in COVID-19 complications.